{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:03:23Z","timestamp":1779800603085,"version":"3.53.1"},"reference-count":264,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T00:00:00Z","timestamp":1764460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T00:00:00Z","timestamp":1764460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10787-025-02062-9","type":"journal-article","created":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T03:09:46Z","timestamp":1764472186000},"page":"17-46","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lingering echoes of SARS-CoV-2: mechanistic insights and management of long COVID syndrome"],"prefix":"10.1007","volume":"34","author":[{"given":"Jagat Pal","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimesh Kumar","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indra Pal","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateek","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,30]]},"reference":[{"key":"2062_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/v13101904","volume":"13","author":"D Acanfora","year":"2021","unstructured":"Acanfora D, Acanfora C, Ciccone MM et al (2021) The cross-talk between thrombosis and inflammatory storm in acute and long-COVID-19: therapeutic targets and clinical cases. Viruses 13:1904","journal-title":"Viruses"},{"key":"2062_CR2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S2213-2600(21)00286-1","volume":"9","author":"D Adeloye","year":"2021","unstructured":"Adeloye D, Elneima O, Daines L et al (2021) The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease. Lancet Respir Med 9:1467\u20131478","journal-title":"Lancet Respir Med"},{"key":"2062_CR3","first-page":"60","volume":"1","author":"S Afrin","year":"2024","unstructured":"Afrin S (2024) Effectiveness of traditional remedies, antivirals, and vaccines against COVID-19. Life 1:60\u201376","journal-title":"Life"},{"key":"2062_CR4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161167","author":"J Ahamed","year":"2022","unstructured":"Ahamed J, Laurence J (2022) Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI161167","journal-title":"J Clin Invest"},{"key":"2062_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417198","volume":"24","author":"LM Ailioaie","year":"2023","unstructured":"Ailioaie LM, Ailioaie C, Litscher G (2023) Gut microbiota and mitochondria: health and pathophysiological aspects of long COVID. Int J Mol Sci 24:17198","journal-title":"Int J Mol Sci"},{"key":"2062_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/01410768211032850","volume":"114","author":"OL Aiyegbusi","year":"2021","unstructured":"Aiyegbusi OL, Hughes SE, Turner G et al (2021) Symptoms, complications and management of long COVID: a review. J R Soc Med 114:428\u2013442","journal-title":"J R Soc Med"},{"key":"2062_CR7","first-page":"205","volume":"45","author":"HK Al-Hakeim","year":"2023","unstructured":"Al-Hakeim HK, Al-Rubaye HT, Jubran AS et al (2023) Increased insulin resistance due to Long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection. Braz J Psychiatry 45:205\u2013215","journal-title":"Braz J Psychiatry"},{"key":"2062_CR8","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.radi.2022.08.009","volume":"28","author":"F Alghamdi","year":"2022","unstructured":"Alghamdi F, Owen R, Ashton REM et al (2022) Post-acute COVID syndrome (long COVID): what should radiographers know and the potential impact for imaging services. Radiography 28:S93\u2013S99. https:\/\/doi.org\/10.1016\/j.radi.2022.08.009","journal-title":"Radiography"},{"key":"2062_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076257","volume":"24","author":"D Apostolo","year":"2023","unstructured":"Apostolo D, D\u2019Onghia D, Tonello S et al (2023) Decreased Gas6 and sAxl plasma levels are associated with hair loss in COVID-19 survivors. Int J Mol Sci 24:6257","journal-title":"Int J Mol Sci"},{"key":"2062_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/acn3.51498","volume":"9","author":"AC Apple","year":"2022","unstructured":"Apple AC, Oddi A, Peluso MJ et al (2022) Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann Clin Transl Neurol 9:221\u2013226","journal-title":"Ann Clin Transl Neurol"},{"key":"2062_CR11","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1111\/jpc.16120","volume":"58","author":"AA Asadi\u2010Pooya","year":"2022","unstructured":"Asadi\u2010Pooya AA, Nemati M, Nemati H (2022) \u2018Long COVID\u2019: symptom persistence in children hospitalised for COVID\u201019. J Paediatr Child Health 58:1836\u20131840","journal-title":"J Paediatr Child Health"},{"key":"2062_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/biom14070835","volume":"14","author":"R Ashmawy","year":"2024","unstructured":"Ashmawy R, Hammouda EA, El-Maradny YA et al (2024) Interplay between comorbidities and long COVID: challenges and multidisciplinary approaches. Biomolecules 14:835","journal-title":"Biomolecules"},{"key":"2062_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100122","author":"M Augustin","year":"2021","unstructured":"Augustin M, Schommers P, Stecher M et al (2021) Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100122","journal-title":"Lancet Reg Health"},{"key":"2062_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069676","author":"D Ayoubkhani","year":"2022","unstructured":"Ayoubkhani D, Bermingham C, Pouwels KB et al (2022) Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. https:\/\/doi.org\/10.1136\/bmj-2021-069676","journal-title":"BMJ"},{"key":"2062_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab297","volume":"4","author":"JB Badenoch","year":"2022","unstructured":"Badenoch JB, Rengasamy ER, Watson C et al (2022) Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Commun 4:fcab297","journal-title":"Brain Commun"},{"key":"2062_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cmi.2021.11.002","volume":"28","author":"F Bai","year":"2022","unstructured":"Bai F, Tomasoni D, Falcinella C et al (2022) Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect 28:611-e9","journal-title":"Clin Microbiol Infect"},{"key":"2062_CR17","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1021\/acschemneuro.2c00482","volume":"13","author":"AM Baig","year":"2022","unstructured":"Baig AM, Greig NH, Gerlach J et al (2022) Underlying causes and treatment modalities for neurological deficits in COVID-19 and long-COVID. ACS Chem Neurosci 13:2934\u20132938","journal-title":"ACS Chem Neurosci"},{"key":"2062_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/v15051173","volume":"15","author":"C Baroni","year":"2023","unstructured":"Baroni C, Potito J, Perticone ME et al (2023) How does long-COVID impact prognosis and the long-term sequelae? Viruses 15:1173","journal-title":"Viruses"},{"key":"2062_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11739-020-02569-9","volume":"16","author":"A Bartoli","year":"2021","unstructured":"Bartoli A, Gabrielli F, Alicandro T et al (2021) COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs. Intern Emerg Med 16:281\u2013308. https:\/\/doi.org\/10.1007\/s11739-020-02569-9","journal-title":"Intern Emerg Med"},{"key":"2062_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e41980","volume":"11","author":"S Batool","year":"2025","unstructured":"Batool S, Chokkakula S, Jeong JH et al (2025) SARS-CoV-2 drug resistance and therapeutic approaches. Heliyon 11:e41980. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e41980","journal-title":"Heliyon"},{"key":"2062_CR21","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41591-021-01433-3","volume":"27","author":"B Blomberg","year":"2021","unstructured":"Blomberg B, Mohn KG-I, Brokstad KA et al (2021) Long COVID in a prospective cohort of home-isolated patients. Nat Med 27:1607\u20131613","journal-title":"Nat Med"},{"key":"2062_CR22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169515","volume":"8","author":"A Bodansky","year":"2023","unstructured":"Bodansky A, Wang C-Y, Saxena A et al (2023) Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients. JCI Insight 8:e169515","journal-title":"JCI Insight"},{"key":"2062_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15386\/mpr-2340","volume":"95","author":"AM Bogariu","year":"2022","unstructured":"Bogariu AM, Dumitrascu DL (2022) Digestive involvement in the long-COVID syndrome. Med Pharm Rep 95:5","journal-title":"Med Pharm Rep"},{"key":"2062_CR24","doi-asserted-by":"publisher","first-page":"1070379","DOI":"10.3389\/fimmu.2022.1070379","volume":"13","author":"V Bonetto","year":"2022","unstructured":"Bonetto V, Pasetto L, Lisi I et al (2022) Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Front Immunol 13:1070379","journal-title":"Front Immunol"},{"key":"2062_CR25","doi-asserted-by":"publisher","first-page":"1129459","DOI":"10.3389\/fimmu.2023.1129459","volume":"14","author":"H Bonilla","year":"2023","unstructured":"Bonilla H, Peluso MJ, Rodgers K et al (2023) Therapeutic trials for long COVID-19: a call to action from the interventions taskforce of the RECOVER initiative. Front Immunol 14:1129459. https:\/\/doi.org\/10.3389\/fimmu.2023.1129459","journal-title":"Front Immunol"},{"key":"2062_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1089\/jicm.2022.0821","volume":"29","author":"J Bradbury","year":"2023","unstructured":"Bradbury J, Wilkinson S, Schloss J (2023) Nutritional support during long COVID: a systematic scoping review. J Integr Complement Med 29:695\u2013704","journal-title":"J Integr Complement Med"},{"key":"2062_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/PSY.0000000000001380","volume":"87","author":"RG Bravo","year":"2025","unstructured":"Bravo RG, Infanti A, Billieux J et al (2025) Unmasking the psychological landscape of long COVID: a cluster-analytical approach. Biopsychosoc Sci Med 87:162\u2013172","journal-title":"Biopsychosoc Sci Med"},{"key":"2062_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0305187","volume":"20","author":"KKO Brien","year":"2025","unstructured":"Brien KKO, Brown DA, Mcduff K, Clair-sullivan NS (2025) Episodic disability framework in the context of long COVID\u202f: Findings from a community- engaged international qualitative study. PLoS ONE 20:e0305187. https:\/\/doi.org\/10.1371\/journal.pone.0305187","journal-title":"PLoS ONE"},{"key":"2062_CR29","doi-asserted-by":"crossref","unstructured":"Buonsenso D, Piazza M, Boner AL, Bellanti JA (2022) Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome. In: Allergy and Asthma Proceedings. p 187","DOI":"10.2500\/aap.2022.43.220018"},{"key":"2062_CR30","doi-asserted-by":"crossref","unstructured":"Buttery S, Philip KEJ, Williams P, et al (2021) Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ open Respir Res 8","DOI":"10.2139\/ssrn.3834303"},{"key":"2062_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/diseases12050095","volume":"12","author":"V Calcaterra","year":"2024","unstructured":"Calcaterra V, Zanelli S, Foppiani A et al (2024) Long COVID in children, adults, and vulnerable populations: a comprehensive overview for an integrated approach. Diseases 12:95","journal-title":"Diseases"},{"key":"2062_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104293","author":"G Captur","year":"2022","unstructured":"Captur G, Moon JC, Topriceanu C-C et al (2022) Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104293","journal-title":"EBioMedicine"},{"key":"2062_CR33","doi-asserted-by":"crossref","unstructured":"Carazo S, Skowronski DM, Laforce Jr R, et al (2022) Physical, psychological, and cognitive profile of post-COVID conditions in healthcare workers, Quebec, Canada. In: Open forum infectious diseases. Oxford University Press, p ofac386","DOI":"10.1101\/2022.03.08.22272057"},{"key":"2062_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-021-00881-x","volume":"11","author":"L Carenzo","year":"2021","unstructured":"Carenzo L, Protti A, Dalla Corte F et al (2021) Short-term health-related quality of life, physical function and psychological consequences of severe COVID-19. Ann Intensive Care 11:91","journal-title":"Ann Intensive Care"},{"key":"2062_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jocn.16150","volume":"33","author":"C Cha","year":"2024","unstructured":"Cha C, Baek G (2024) Symptoms and management of long COVID: a scoping review. J Clin Nurs 33:11\u201328","journal-title":"J Clin Nurs"},{"key":"2062_CR36","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1007\/s10787-025-01807-w","volume":"33","author":"D Chatterjee","year":"2025","unstructured":"Chatterjee D, Maparu K (2025) Long COVID syndrome: exploring therapies for managing and overcoming persistent symptoms. Inflammopharmacology 33:4097\u20134113","journal-title":"Inflammopharmacology"},{"key":"2062_CR37","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.86015","volume":"12","author":"B Chen","year":"2023","unstructured":"Chen B, Julg B, Mohandas S, Bradfute SB (2023) Viral persistence, reactivation, and mechanisms of long COVID. Elife 12:e86015","journal-title":"Elife"},{"key":"2062_CR38","doi-asserted-by":"crossref","unstructured":"Chen C-H, Chen P-C, Liu X-L, et al (2025) Assessment of Pulmonary Function in Children with Post-Acute Sequelae of COVID (PASC) Using Impulse Oscillometry and the Role of Vaccination","DOI":"10.21203\/rs.3.rs-7135121\/v1"},{"key":"2062_CR39","doi-asserted-by":"crossref","unstructured":"Chen C, Haupert SR, Zimmermann L, et al (2021) Global prevalence of post-acute sequelae of COVID-19 (PASC) or long COVID: a meta-analysis and systematic review. MedRxiv 2011\u20132021","DOI":"10.1101\/2021.11.15.21266377"},{"key":"2062_CR40","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu DI, Guo W et al (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130:2620\u20132629","journal-title":"J Clin Invest"},{"key":"2062_CR41","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.7189\/jogh.12.05011","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Zhang SX, Yin A, Y\u00e1\u00f1ez JA (2022) Mental health symptoms during the COVID-19 pandemic in developing countries: a systematic review and meta-analysis. J Glob Health 12:5011","journal-title":"J Glob Health"},{"key":"2062_CR42","doi-asserted-by":"publisher","first-page":"175628482211184","DOI":"10.1177\/17562848221118403","volume":"15","author":"A Choudhury","year":"2022","unstructured":"Choudhury A, Tariq R, Jena A et al (2022) Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis. Therap Adv Gastroenterol 15:17562848221118404","journal-title":"Therap Adv Gastroenterol"},{"key":"2062_CR43","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1016\/j.jfma.2023.03.022","volume":"123","author":"H-J Chuang","year":"2024","unstructured":"Chuang H-J, Lin C-W, Hsiao M-Y et al (2024) Long COVID and rehabilitation. J Formos Med Assoc 123:S61\u2013S69","journal-title":"J Formos Med Assoc"},{"key":"2062_CR44","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/neurosci3020021","volume":"3","author":"J Colombo","year":"2022","unstructured":"Colombo J, Weintraub MI, Munoz R et al (2022) Long COVID and the autonomic nervous system: the journey from dysautonomia to therapeutic neuro-modulation through the retrospective analysis of 152 patients. Neurosci 3:300\u2013310","journal-title":"Neurosci"},{"key":"2062_CR45","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jtha.2022.10.013","volume":"21","author":"A Constantinescu-Bercu","year":"2023","unstructured":"Constantinescu-Bercu A, Kessler A, de Groot R et al (2023) Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome. J Thromb Haemost 21:94\u2013100","journal-title":"J Thromb Haemost"},{"key":"2062_CR46","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/jnci\/djac057","volume":"114","author":"A Cortellini","year":"2022","unstructured":"Cortellini A, Gennari A, Pommeret F et al (2022) COVID-19 sequelae and the host proinflammatory response: an analysis from the OnCovid registry. JNCI J Natl Cancer Inst 114:979\u2013987","journal-title":"JNCI J Natl Cancer Inst"},{"key":"2062_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195787","volume":"11","author":"M Covino","year":"2022","unstructured":"Covino M, Russo A, Salini S et al (2022) Long-term effects of hospitalization for COVID-19 on frailty and quality of life in older adults\u2265 80 years. J Clin Med 11:5787","journal-title":"J Clin Med"},{"key":"2062_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1648","author":"H Crook","year":"2021","unstructured":"Crook H, Raza S, Nowell J et al (2021) Long covid\u2014mechanisms, risk factors, and management. BMJ. https:\/\/doi.org\/10.1136\/bmj.n1648","journal-title":"BMJ"},{"key":"2062_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.laheal.2023.09.001","volume":"2","author":"L Cummings","year":"2024","unstructured":"Cummings L (2024) Cognitive-linguistic difficulties in adults with long COVID: a follow-up study. Lang Heal 2:1\u201321","journal-title":"Lang Heal"},{"key":"2062_CR50","doi-asserted-by":"crossref","unstructured":"Cysique LA, Jakabek D, Bracken SG, et al (2022) Post-acute COVID-19 cognitive impairment and decline uniquely associate with kynurenine pathway activation: a longitudinal observational study. Medrxiv 2006\u20132022","DOI":"10.1101\/2022.06.07.22276020"},{"key":"2062_CR51","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ijid.2022.09.035","volume":"125","author":"V Daitch","year":"2022","unstructured":"Daitch V, Yelin D, Awwad M et al (2022) Characteristics of long-COVID among older adults: a cross-sectional study. Int J Infect Dis 125:287\u2013293","journal-title":"Int J Infect Dis"},{"key":"2062_CR52","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/BCR.0b013e3181711152","volume":"29","author":"M Dalamaga","year":"2008","unstructured":"Dalamaga M, Karmaniolas K, Nikolaidou A, Papadavid E (2008) Hypocalcemia, hypomagnesemia, and hypokalemia following hydrofluoric acid chemical injury. J Burn Care Res 29:541\u2013543","journal-title":"J Burn Care Res"},{"key":"2062_CR53","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.7861\/clinmed.2020-0896","volume":"21","author":"M Dani","year":"2021","unstructured":"Dani M, Dirksen A, Taraborrelli P et al (2021) Autonomic dysfunction in \u2018long COVID\u2019: rationale, physiology and management strategies. Clin Med (Northfield Il) 21:e63\u2013e67","journal-title":"Clin Med (Northfield Il)"},{"key":"2062_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmv.29077","volume":"95","author":"S Das","year":"2023","unstructured":"Das S (2023) Exploring the mechanisms of long COVID\u202f: insights from computational analysis of SARS - CoV - 2 gene expression and symptom associations. J Med Syst 95:1\u201319. https:\/\/doi.org\/10.1002\/jmv.29077","journal-title":"J Med Syst"},{"key":"2062_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101019","author":"HE Davis","year":"2021","unstructured":"Davis HE, Assaf GS, McCorkell L et al (2021) Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinMed. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101019","journal-title":"EClinMed"},{"key":"2062_CR56","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21:133\u2013146. https:\/\/doi.org\/10.1038\/s41579-022-00846-2","journal-title":"Nat Rev Microbiol"},{"key":"2062_CR57","doi-asserted-by":"publisher","first-page":"e1106","DOI":"10.1210\/clinem\/dgad207","volume":"108","author":"L Di Filippo","year":"2023","unstructured":"Di Filippo L, Frara S, Nannipieri F et al (2023) Low vitamin D levels are associated with long COVID syndrome in COVID-19 survivors. J Clin Endocrinol Metab 108:e1106\u2013e1116","journal-title":"J Clin Endocrinol Metab"},{"key":"2062_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23168-y","volume":"12","author":"L Di Gennaro","year":"2022","unstructured":"Di Gennaro L, Valentini P, Sorrentino S et al (2022) Extended coagulation profile of children with Long Covid: a prospective study. Sci Rep 12:18392","journal-title":"Sci Rep"},{"key":"2062_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/MCG.0000000000001424","volume":"55","author":"Z Dong","year":"2021","unstructured":"Dong Z, Xiang B-J, Jiang M et al (2021) The prevalence of gastrointestinal symptoms, abnormal liver function, digestive system disease and liver disease in COVID-19 infection: a systematic review and meta-analysis. J Clin Gastroenterol 55:67\u201376","journal-title":"J Clin Gastroenterol"},{"key":"2062_CR60","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3892\/etm.2022.11290","volume":"23","author":"V Efstathiou","year":"2022","unstructured":"Efstathiou V, Stefanou M-I, Demetriou M et al (2022) Long COVID and neuropsychiatric manifestations. Exp Ther Med 23:363","journal-title":"Exp Ther Med"},{"key":"2062_CR61","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1038\/s41598-024-52908-5","volume":"14","author":"M Egger","year":"2024","unstructured":"Egger M, Wimmer C, Stummer S et al (2024) Reduced health-related quality of life, fatigue, anxiety and depression affect COVID-19 patients in the long-term after chronic critical illness. Sci Rep 14:3016","journal-title":"Sci Rep"},{"key":"2062_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2022.101012","volume":"40","author":"SA Elseidy","year":"2022","unstructured":"Elseidy SA, Awad AK, Vorla M et al (2022) Cardiovascular complications in the Post-Acute COVID-19 syndrome (PACS). IJC Heart Vasc 40:101012","journal-title":"IJC Heart Vasc"},{"key":"2062_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104552","author":"E Esp\u00edn","year":"2023","unstructured":"Esp\u00edn E, Yang C, Shannon CP et al (2023) Cellular and molecular biomarkers of long COVID: a scoping review. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104552","journal-title":"EBioMedicine"},{"key":"2062_CR64","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1038\/s41467-022-34068-0","volume":"13","author":"MM Etter","year":"2022","unstructured":"Etter MM, Martins TA, Kulsvehagen L et al (2022) Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nat Commun 13:6777","journal-title":"Nat Commun"},{"key":"2062_CR65","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2213-2600(22)00127-8","volume":"10","author":"RA Evans","year":"2022","unstructured":"Evans RA, Leavy OC, Richardson M et al (2022) Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med 10:761\u2013775","journal-title":"Lancet Respir Med"},{"key":"2062_CR66","unstructured":"Fairlie T, Vaz L, Morrow A, Malone L (2023) Evaluating and supporting children and adolescents presenting with post-COVID conditions"},{"key":"2062_CR67","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s11357-024-01487-4","volume":"47","author":"M Fekete","year":"2025","unstructured":"Fekete M, Lehoczki A, Szappanos \u00c1 et al (2025) Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health. GeroScience 47:745\u2013779","journal-title":"GeroScience"},{"key":"2062_CR68","doi-asserted-by":"publisher","first-page":"930","DOI":"10.17269\/s41997-022-00695-9","volume":"113","author":"DE Feldman","year":"2022","unstructured":"Feldman DE, Boudrias M-H, Mazer B (2022) Long COVID symptoms in a population-based sample of persons discharged home from hospital. Can J Public Health 113:930\u2013939","journal-title":"Can J Public Health"},{"key":"2062_CR69","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Casta\u00f1eda A, Lu P, Geraghty AC, et al (2022) Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. BioRxiv","DOI":"10.1101\/2022.01.07.475453"},{"key":"2062_CR70","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s15010-021-01696-5","volume":"50","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2022","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C (2022) Long COVID: current definition. Infection 50:285\u2013286","journal-title":"Infection"},{"key":"2062_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18052621","volume":"18","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2021","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Palacios-Ce\u00f1a D, G\u00f3mez-Mayordomo V et al (2021) Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health 18:2621","journal-title":"Int J Environ Res Public Health"},{"key":"2062_CR72","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151544","volume":"6","author":"JK Files","year":"2021","unstructured":"Files JK, Sarkar S, Fram TR et al (2021) Duration of post\u2013COVID-19 symptoms is associated with sustained SARS-CoV-2\u2013specific immune responses. JCI Insight 6:e151544","journal-title":"JCI Insight"},{"issue":"7","key":"2062_CR73","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s11739-025-04051-w","volume":"20","author":"M Floridia","year":"2025","unstructured":"Floridia M, Weimer LE, Rovere Querini P et al (2025) Persistence of symptoms in long-COVID: follow-up trajectories of 30 symptoms in 755 patients from a national multicenter study from Italy. Intern Emerg Med 20(7):2041\u20132055","journal-title":"Intern Emerg Med"},{"key":"2062_CR74","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbi.2023.01.006","volume":"109","author":"C Franke","year":"2023","unstructured":"Franke C, Boesl F, Goereci Y et al (2023) Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome. Brain Behav Immun 109:139\u2013143","journal-title":"Brain Behav Immun"},{"key":"2062_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2024.1509289","volume":"15","author":"Y Galipeau","year":"2024","unstructured":"Galipeau Y, Cooper C, Langlois MA (2024) Autoantibodies in COVID-19: implications for disease severity and clinical outcomes. Front Immunol 15:1\u201316. https:\/\/doi.org\/10.3389\/fimmu.2024.1509289","journal-title":"Front Immunol"},{"key":"2062_CR76","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41590-025-02135-5","volume":"26","author":"Y Gao","year":"2025","unstructured":"Gao Y, Cai C, Adamo S et al (2025) Identification of soluble biomarkers that associate with distinct manifestations of long COVID. Nat Immunol 26:692\u2013705","journal-title":"Nat Immunol"},{"key":"2062_CR77","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s10875-021-01083-7","volume":"41","author":"J Garc\u00eda-Abell\u00e1n","year":"2021","unstructured":"Garc\u00eda-Abell\u00e1n J, Padilla S, Fern\u00e1ndez-Gonz\u00e1lez M et al (2021) Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study. J Clin Immunol 41:1490\u20131501","journal-title":"J Clin Immunol"},{"key":"2062_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13030302","author":"M Gatti","year":"2021","unstructured":"Gatti M, De Ponti F (2021) Drug repurposing in the COVID-19 era: insights from case studies showing pharmaceutical peculiarities. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13030302","journal-title":"Pharmaceutics"},{"key":"2062_CR79","doi-asserted-by":"publisher","first-page":"1034169","DOI":"10.3389\/fnut.2022.1034169","volume":"9","author":"NB Gaylis","year":"2022","unstructured":"Gaylis NB, Kreychman I, Sagliani J et al (2022a) The results of a unique dietary supplement (nutraceutical formulation) used to treat the symptoms of long-haul COVID. Front Nutr 9:1034169","journal-title":"Front Nutr"},{"key":"2062_CR80","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/cid\/ciac226","volume":"75","author":"NB Gaylis","year":"2022","unstructured":"Gaylis NB, Ritter A, Kelly SA et al (2022b) Reduced cell surface levels of CC chemokine receptor 5 and immunosuppression in long coronavirus disease 2019 syndrome. Clin Infect Dis 75:1232\u20131234","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2062_CR81","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.3390\/nu13113964","volume":"13","author":"M G\u00e9rard","year":"2021","unstructured":"G\u00e9rard M, Mahmutovic M, Malgras A et al (2021) (2021) Long-term evolution of malnutrition and loss of muscle strength after COVID-19: a major and neglected component of long COVID-19. Nutrients 13(11):3964","journal-title":"Nutrients"},{"key":"2062_CR82","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.160989","volume":"7","author":"LB Giron","year":"2022","unstructured":"Giron LB, Peluso MJ, Ding J et al (2022) Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-\u03baB signaling. JCI Insight 7:e160989","journal-title":"JCI Insight"},{"key":"2062_CR83","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3390\/pathogens10060763","volume":"10","author":"JE Gold","year":"2021","unstructured":"Gold JE, Okyay RA, Licht WE, Hurley DJ (2021) Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens 10:763","journal-title":"Pathogens"},{"key":"2062_CR84","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1159\/000540919","volume":"59","author":"A Gorenshtein","year":"2025","unstructured":"Gorenshtein A, Leibovitch L, Liba T et al (2025) Gender disparities in neurological symptoms of long COVID: a systematic review and meta-analysis. Neuroepidemiology 59:426\u2013440","journal-title":"Neuroepidemiology"},{"key":"2062_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2024.1482917","volume":"15","author":"SL Grach","year":"2024","unstructured":"Grach SL, Dudenkov DV, Pollack B et al (2024) Overlapping conditions in Long COVID at a multisite academic center. Front Neurol 15:1\u201312. https:\/\/doi.org\/10.3389\/fneur.2024.1482917","journal-title":"Front Neurol"},{"key":"2062_CR86","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","volume":"27","author":"C Greene","year":"2024","unstructured":"Greene C, Connolly R, Brennan D et al (2024) Blood\u2013brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci 27:421\u2013432","journal-title":"Nat Neurosci"},{"key":"2062_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.866153","volume":"13","author":"M Guasp","year":"2022","unstructured":"Guasp M, Mu\u00f1oz-S\u00e1nchez G, Mart\u00ednez-Hern\u00e1ndez E et al (2022) CSF biomarkers in COVID-19 associated encephalopathy and encephalitis predict long-term outcome. Front Immunol 13:866153","journal-title":"Front Immunol"},{"key":"2062_CR88","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3390\/metabo12111026","volume":"12","author":"VP Guntur","year":"2022","unstructured":"Guntur VP, Nemkov T, de Boer E et al (2022) Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC). Metabolites 12:1026","journal-title":"Metabolites"},{"key":"2062_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/cph4.70019","volume":"15","author":"G Gupta","year":"2025","unstructured":"Gupta G, Buonsenso D, Wood J et al (2025) Mechanistic insights into long Covid: viral persistence, immune dysregulation, and multi\u2010organ dysfunction. Compr Physiol 15:e70019","journal-title":"Compr Physiol"},{"key":"2062_CR90","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12967-022-03346-2","volume":"20","author":"M Haffke","year":"2022","unstructured":"Haffke M, Freitag H, Rudolf G et al (2022) Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME\/CFS). J Transl Med 20:138","journal-title":"J Transl Med"},{"key":"2062_CR91","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.immuni.2024.05.010","volume":"57","author":"RE Hamlin","year":"2024","unstructured":"Hamlin RE, Blish CA (2024) Challenges and opportunities in long COVID research. Immunity 57:1195\u20131214","journal-title":"Immunity"},{"key":"2062_CR92","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3233\/WOR-220437","volume":"75","author":"S Hanafy","year":"2023","unstructured":"Hanafy S, Colantonio A, Mollayeva T et al (2023) Employment and accommodation needs and the effect of COVID-19 on men and women with traumatic brain injury. Work 75:41\u201358. https:\/\/doi.org\/10.3233\/WOR-220437","journal-title":"Work"},{"key":"2062_CR93","doi-asserted-by":"publisher","first-page":"1070994","DOI":"10.3389\/fimmu.2022.1070994","volume":"13","author":"S Haunhorst","year":"2022","unstructured":"Haunhorst S, Bloch W, Javelle F et al (2022) A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients\u2013indications for their potential involvement in the development of long COVID? Front Immunol 13:1070994","journal-title":"Front Immunol"},{"key":"2062_CR94","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.amjmed.2023.08.008","volume":"138","author":"HB Hawley","year":"2025","unstructured":"Hawley HB (2025) Long COVID: clinical findings, pathology, and endothelial molecular mechanisms. Am J Med 138:91\u201397","journal-title":"Am J Med"},{"key":"2062_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2024.1457672","volume":"15","author":"X He","year":"2024","unstructured":"He X, Zhang X, Zhong W (2024) Emerging small-molecule antiviral agents in long COVID prevention. Front Pharmacol 15:1\u20138. https:\/\/doi.org\/10.3389\/fphar.2024.1457672","journal-title":"Front Pharmacol"},{"issue":"17","key":"2062_CR96","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79(17):e263\u2013e421","journal-title":"J Am Coll Cardiol"},{"key":"2062_CR97","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"J Helms","year":"2020","unstructured":"Helms J, Tacquard C, Severac F et al (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46:1089\u20131098","journal-title":"Intensive Care Med"},{"key":"2062_CR98","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/cid\/ciab408","volume":"73","author":"JL Hirschtick","year":"2021","unstructured":"Hirschtick JL, Titus AR, Slocum E et al (2021a) Population-based estimates of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) prevalence and characteristics. Clin Infect Dis 73:2055\u20132064","journal-title":"Clin Infect Dis"},{"key":"2062_CR99","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab408","author":"JL Hirschtick","year":"2021","unstructured":"Hirschtick JL, Titus AR, Slocum E et al (2021b) Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciab408","journal-title":"Clin Infect Dis"},{"key":"2062_CR100","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.cjca.2024.02.014","volume":"40","author":"A Hoagland","year":"2024","unstructured":"Hoagland A, Kipping S, Cpmhn C (2024) Challenges in promoting health equity and reducing disparities in access across new and established technologies. Can J Cardiol 40:1154\u20131167. https:\/\/doi.org\/10.1016\/j.cjca.2024.02.014","journal-title":"Can J Cardiol"},{"key":"2062_CR101","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S2215-0366(20)30168-1","volume":"7","author":"EA Holmes","year":"2020","unstructured":"Holmes EA, O\u2019Connor RC, Perry VH et al (2020) Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry 7:547\u2013560","journal-title":"Lancet Psychiatry"},{"key":"2062_CR102","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.amjmed.2020.12.007","volume":"134","author":"R Horwitz","year":"2021","unstructured":"Horwitz R, Maizes V (2021) Integrative medicine and the long hauler syndrome\u2014we meet again. Am J Med 134:418\u2013419","journal-title":"Am J Med"},{"key":"2062_CR103","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/thoraxjnl-2021-218582","volume":"77","author":"L Houchen-Wolloff","year":"2022","unstructured":"Houchen-Wolloff L, Poinasamy K, Holmes K et al (2022) Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19. Thorax 77:717\u2013720","journal-title":"Thorax"},{"key":"2062_CR104","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/microorganisms12020272","volume":"12","author":"H Hussain","year":"2024","unstructured":"Hussain H, Paidas MJ, Rajalakshmi R et al (2024) Dermatologic changes in experimental model of long COVID. Microorganisms 12:272","journal-title":"Microorganisms"},{"key":"2062_CR105","first-page":"3038","volume":"26","author":"AARM Hussein","year":"2022","unstructured":"Hussein AARM, Galal I, Amin MT et al (2022) Prevalence of vitamin D deficiency among patients attending Post COVID-19 follow-up clinic: a cross-sectional study. Eur Rev Med Pharmacol Sci 26:3038","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2062_CR106","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.911","volume":"10","author":"B Jarrott","year":"2022","unstructured":"Jarrott B, Head R, Pringle KG et al (2022) \u201cLONG COVID\u201d\u2014a hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol Res Perspect 10:e00911","journal-title":"Pharmacol Res Perspect"},{"key":"2062_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1393782","volume":"16","author":"C Jiang","year":"2025","unstructured":"Jiang C, Wang B, Qu Y et al (2025) Nonlinear association between depressive symptoms and homeostasis model assessment of insulin resistance: a cross-sectional analysis in the American population. Front Psychiatry 16:1393782","journal-title":"Front Psychiatry"},{"key":"2062_CR108","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10067-021-05942-x","volume":"41","author":"F Karaarslan","year":"2022","unstructured":"Karaarslan F, G\u00fcneri FD, Karde\u015f S (2022) Long COVID: rheumatologic\/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol 41:289\u2013296","journal-title":"Clin Rheumatol"},{"key":"2062_CR109","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s13679-019-00360-2","volume":"8","author":"I Karampela","year":"2019","unstructured":"Karampela I, Christodoulatos GS, Dalamaga M (2019) The role of adipose tissue and adipokines in sepsis: inflammatory and metabolic considerations, and the obesity paradox. Curr Obes Rep 8:434\u2013457","journal-title":"Curr Obes Rep"},{"key":"2062_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020301","volume":"12","author":"I Karampela","year":"2022","unstructured":"Karampela I, Christodoulatos GS, Vallianou N et al (2022) Circulating chemerin and its kinetics may be a useful diagnostic and prognostic biomarker in critically ill patients with sepsis: a prospective study. Biomolecules 12:301","journal-title":"Biomolecules"},{"key":"2062_CR111","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jcrc.2017.05.004","volume":"41","author":"I Karampela","year":"2017","unstructured":"Karampela I, Kandri E, Antonakos G et al (2017) Kinetics of circulating fetuin-A may predict mortality independently from adiponectin, high molecular weight adiponectin and prognostic factors in critically ill patients with sepsis: a prospective study. J Crit Care 41:78\u201385","journal-title":"J Crit Care"},{"key":"2062_CR112","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3390\/ph15030345","volume":"15","author":"I Karosanidze","year":"2022","unstructured":"Karosanidze I, Kiladze U, Kirtadze N et al (2022) Efficacy of adaptogens in patients with long COVID-19: a randomized, quadruple-blind, placebo-controlled trial. Pharmaceuticals 15:345","journal-title":"Pharmaceuticals"},{"key":"2062_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292630","volume":"18","author":"CE Kennelly","year":"2023","unstructured":"Kennelly CE, Nguyen ATP, Sheikhan NY et al (2023) The lived experience of long COVID: a qualitative study of mental health, quality of life, and coping. PLoS ONE 18:e0292630","journal-title":"PLoS ONE"},{"key":"2062_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmolb.2023.1157651","volume":"10","author":"G Kenny","year":"2023","unstructured":"Kenny G, Townsend L, Savinelli S, Mallon PWG (2023) Long COVID: clinical characteristics, proposed pathogenesis and potential therapeutic targets. Front Mol Biosci 10:1\u201314. https:\/\/doi.org\/10.3389\/fmolb.2023.1157651","journal-title":"Front Mol Biosci"},{"key":"2062_CR115","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12985-020-01415-w","volume":"17","author":"S Khadke","year":"2020","unstructured":"Khadke S, Ahmed N, Ahmed N et al (2020) Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents. Virol J 17:154","journal-title":"Virol J"},{"key":"2062_CR116","first-page":"16","volume":"105","author":"V Khetpal","year":"2022","unstructured":"Khetpal V, Berkowitz J, Vijayakumar S et al (2022) Long-term cardiovascular manifestations and complications of COVID-19: spectrum and approach to diagnosis and management. R I Med J 105:16\u201322","journal-title":"R I Med J"},{"key":"2062_CR117","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3390\/covid4110120","volume":"4","author":"J Kim","year":"2024","unstructured":"Kim J, Duru EE, Weir P, Lee S (2024) Long COVID is associated with decreased quality of life and increased mental disability. Covid 4:1719\u20131730. https:\/\/doi.org\/10.3390\/covid4110120","journal-title":"Covid"},{"issue":"7985","key":"2062_CR118","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","volume":"623","author":"J Klein","year":"2022","unstructured":"Klein J, Wood J, Jaycox J et al (2022) Distinguishing features of long COVID identified through immune profiling. Nature 623(7985):139\u2013148","journal-title":"Nature"},{"key":"2062_CR119","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","volume":"623","author":"J Klein","year":"2023","unstructured":"Klein J, Wood J, Jaycox JR et al (2023) Distinguishing features of long COVID identified through immune profiling. Nature 623:139\u2013148. https:\/\/doi.org\/10.1038\/s41586-023-06651-y","journal-title":"Nature"},{"key":"2062_CR120","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1136\/jnnp-2024-333950","volume":"95","author":"SAB Knapp","year":"2024","unstructured":"Knapp SAB, Austin DS, Aita SL et al (2024) Neurocognitive and psychiatric outcomes associated with postacute COVID-19 infection without severe medical complication: a meta-analysis. J Neurol Neurosurg Psychiatry 95:1207\u20131216","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2062_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233882","volume":"11","author":"M Kobusiak-Prokopowicz","year":"2022","unstructured":"Kobusiak-Prokopowicz M, Fu\u0142ek K, Fu\u0142ek M et al (2022) Cardiovascular, pulmonary, and neuropsychiatric short-and long-term complications of COVID-19. Cells 11:3882","journal-title":"Cells"},{"key":"2062_CR122","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/eurheartj\/ehab075","volume":"42","author":"T Kotecha","year":"2021","unstructured":"Kotecha T, Knight DS, Razvi Y et al (2021) Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J 42:1866\u20131878","journal-title":"Eur Heart J"},{"key":"2062_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-024-03731-1","author":"F Kov\u00e1cs","year":"2024","unstructured":"Kov\u00e1cs F, Posvai T, Zs\u00e1ry E et al (2024) Long COVID syndrome in children: neutrophilic granulocyte dysfunction and its correlation with disease severity. Pediatr Res. https:\/\/doi.org\/10.1038\/s41390-024-03731-1","journal-title":"Pediatr Res"},{"key":"2062_CR124","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00186-23","volume":"37","author":"A Kramer","year":"2024","unstructured":"Kramer A, Lexow F, Bludau A et al (2024) How long do bacteria, fungi, protozoa, and viruses retain their replication capacity on inanimate surfaces? A systematic review examining environmental resilience versus healthcare-associated infection risk by \u201cfomite-borne risk assessment.\u201d Clin Microbiol Rev 37:e00186-23","journal-title":"Clin Microbiol Rev"},{"key":"2062_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01623-4","volume":"21","author":"A Kruger","year":"2022","unstructured":"Kruger A, Vlok M, Turner S et al (2022) Proteomics of fibrin amyloid microclots in long COVID\/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc Diabetol 21:190","journal-title":"Cardiovasc Diabetol"},{"key":"2062_CR126","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/pcn.13508","volume":"77","author":"T Kubota","year":"2023","unstructured":"Kubota T, Kuroda N, Sone D (2023) Neuropsychiatric aspects of long COVID: a comprehensive review. Psychiatry Clin Neurosci 77:84\u201393","journal-title":"Psychiatry Clin Neurosci"},{"key":"2062_CR127","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10456-023-09885-6","volume":"26","author":"T Kuchler","year":"2023","unstructured":"Kuchler T, G\u00fcnthner R, Ribeiro A et al (2023) Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation. Angiogenesis 26:547\u2013563","journal-title":"Angiogenesis"},{"key":"2062_CR128","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1136\/military-2023-002399","volume":"170","author":"P Ladlow","year":"2024","unstructured":"Ladlow P, Barker-Davies R, Hill O et al (2024) Use of symptom-guided physical activity and exercise rehabilitation for COVID-19 and other postviral conditions. BMJ Mil Health 170:510\u2013515","journal-title":"BMJ Mil Health"},{"key":"2062_CR129","doi-asserted-by":"publisher","first-page":"1085988","DOI":"10.3389\/fmed.2023.1085988","volume":"10","author":"Y-J Lai","year":"2023","unstructured":"Lai Y-J, Liu S-H, Manachevakul S et al (2023) Biomarkers in long COVID-19: a systematic review. Front Med 10:1085988","journal-title":"Front Med"},{"key":"2062_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658896","volume":"12","author":"A Lange","year":"2021","unstructured":"Lange A, Lange J, Jasku\u0142a E (2021) Cytokine overproduction and immune system dysregulation in alloHSCT and COVID-19 patients. Front Immunol 12:658896","journal-title":"Front Immunol"},{"key":"2062_CR131","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1134\/S2079057022040105","volume":"12","author":"ES Lapteva","year":"2022","unstructured":"Lapteva ES, Ariev AL, Arieva GT et al (2022) On the role of geriatric services in the diagnosis and monitoring of outcomes of post-Covid syndrome. Adv Gerontol 12:357\u2013369","journal-title":"Adv Gerontol"},{"key":"2062_CR132","doi-asserted-by":"crossref","unstructured":"Laubscher GJ, Khan MA, Venter C, et al (2023) Treatment of Long COVID symptoms with triple anticoagulant therapy","DOI":"10.21203\/rs.3.rs-2697680\/v1"},{"key":"2062_CR133","doi-asserted-by":"crossref","unstructured":"Lavolpe S, Beretta N, Bonaldi S, et al (2024) Medium-and long-term effects of COVID-19 in a population of patients admitted to the intensive care unit: cognitive and psychological sequelae and quality of life six months and one year after discharge. In: Healthcare. MDPI, p 1624","DOI":"10.3390\/healthcare12161624"},{"key":"2062_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102146","author":"F Legler","year":"2023","unstructured":"Legler F, Meyer-Arndt L, M\u00f6dl L et al (2023) Long-term symptom severity and clinical biomarkers in post-COVID-19\/chronic fatigue syndrome: results from a prospective observational cohort. EClinicalMedicine. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102146","journal-title":"EClinicalMedicine"},{"key":"2062_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136082","volume":"26","author":"G-H Li","year":"2025","unstructured":"Li G-H, Han F-F, Kalafatis E et al (2025) Systems modeling reveals shared metabolic dysregulation and potential treatments in ME\/CFS and long COVID. Int J Mol Sci 26:6082","journal-title":"Int J Mol Sci"},{"key":"2062_CR136","doi-asserted-by":"crossref","unstructured":"Li G-H, Han F, Kong Q-P, Xiao W (2024) Systems Modeling Reveals Shared Metabolic Dysregulation and Novel Therapeutic Treatments in ME\/CFS and Long COVID. bioRxiv 2006\u20132024","DOI":"10.1101\/2024.06.17.599450"},{"key":"2062_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01640-z","author":"J Li","year":"2023","unstructured":"Li J, Zhou Y, Ma J et al (2023) The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-023-01640-z","journal-title":"Signal Transduct Target Ther"},{"key":"2062_CR138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010359","volume":"18","author":"KM Littlefield","year":"2022","unstructured":"Littlefield KM, Watson RO, Schneider JM et al (2022) SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog 18:e1010359","journal-title":"PLoS Pathog"},{"key":"2062_CR139","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/gutjnl-2021-325989","volume":"71","author":"Q Liu","year":"2022","unstructured":"Liu Q, Mak JWY, Su Q et al (2022) Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 71:544\u2013552","journal-title":"Gut"},{"key":"2062_CR140","doi-asserted-by":"publisher","first-page":"12421","DOI":"10.3390\/ijms222212421","volume":"22","author":"XY Loke","year":"2021","unstructured":"Loke XY, Imran SAM, Tye GJ et al (2021) Immunomodulation and regenerative capacity of MSCs for long-COVID. Int J Mol Sci 22:12421","journal-title":"Int J Mol Sci"},{"key":"2062_CR141","doi-asserted-by":"publisher","first-page":"12420","DOI":"10.1038\/s41598-023-39049-x","volume":"13","author":"Y L\u00f3pez-Hern\u00e1ndez","year":"2023","unstructured":"L\u00f3pez-Hern\u00e1ndez Y, Mon\u00e1rrez-Espino J, L\u00f3pez DAG et al (2023a) The plasma metabolome of long COVID patients two years after infection. Sci Rep 13:12420","journal-title":"Sci Rep"},{"key":"2062_CR142","doi-asserted-by":"publisher","first-page":"1100486","DOI":"10.3389\/fmolb.2023.1100486","volume":"10","author":"Y L\u00f3pez-Hern\u00e1ndez","year":"2023","unstructured":"L\u00f3pez-Hern\u00e1ndez Y, Oropeza-Valdez JJ, Garc\u00eda Lopez DA et al (2023b) Untargeted analysis in post-COVID-19 patients reveals dysregulated lipid pathways two years after recovery. Front Mol Biosci 10:1100486","journal-title":"Front Mol Biosci"},{"key":"2062_CR143","doi-asserted-by":"publisher","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","volume":"11","author":"S Lopez-Leon","year":"2021","unstructured":"Lopez-Leon S, Wegman-Ostrosky T, Perelman C et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 11:16144","journal-title":"Sci Rep"},{"key":"2062_CR144","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mSystems.00122-21","volume":"6","author":"R Lordan","year":"2021","unstructured":"Lordan R, Rando HM, Greene CS (2021) Dietary supplements and nutraceuticals under investigation for COVID-19 prevention and treatment. mSystems 6:10\u20131128","journal-title":"mSystems"},{"key":"2062_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms10010153","volume":"10","author":"TJ Louis","year":"2022","unstructured":"Louis TJ, Qasem A, Abdelli LS, Naser SA (2022) Extra-pulmonary complications in SARS-CoV-2 infection: a comprehensive multi organ-system review. Microorganisms 10:1\u201334. https:\/\/doi.org\/10.3390\/microorganisms10010153","journal-title":"Microorganisms"},{"key":"2062_CR146","doi-asserted-by":"crossref","unstructured":"Low R, Low R, Akrami A (2020) A cytokine-based model for the pathophysiology of long COVID symptoms","DOI":"10.31219\/osf.io\/7gcnv"},{"key":"2062_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1011936","volume":"10","author":"RN Low","year":"2023","unstructured":"Low RN, Low RJ, Akrami A (2023) A review of cytokine-based pathophysiology of long COVID symptoms. Front Med 10:1011936","journal-title":"Front Med"},{"key":"2062_CR148","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","volume":"41","author":"W Luo","year":"2020","unstructured":"Luo W, Li Y-X, Jiang L-J et al (2020) Targeting JAK-STAT signaling to control cytokine release syndrome in COVID-19. Trends Pharmacol Sci 41:531\u2013543","journal-title":"Trends Pharmacol Sci"},{"key":"2062_CR149","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11481-020-09944-5","volume":"15","author":"J Machhi","year":"2020","unstructured":"Machhi J, Herskovitz J, Senan AM et al (2020) The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol 15:359\u2013386. https:\/\/doi.org\/10.1007\/s11481-020-09944-5","journal-title":"J Neuroimmune Pharmacol"},{"key":"2062_CR150","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/pm\/pnab341","volume":"23","author":"R Magdy","year":"2022","unstructured":"Magdy R, Eid RA, Fathy W et al (2022) Characteristics and risk factors of persistent neuropathic pain in recovered COVID-19 patients. Pain Med 23:774\u2013781","journal-title":"Pain Med"},{"key":"2062_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.748886","volume":"12","author":"R Maldonado","year":"2021","unstructured":"Maldonado R, Drago F (2021) Drug repurposing for COVID-19 therapy. Front Pharmacol 12:748886","journal-title":"Front Pharmacol"},{"key":"2062_CR152","doi-asserted-by":"publisher","first-page":"e849","DOI":"10.1016\/S2666-7568(22)00245-8","volume":"3","author":"V Mansell","year":"2022","unstructured":"Mansell V, Dykgraaf SH, Kidd M, Goodyear-Smith F (2022) Long COVID and older people. Lancet Heal Longev 3:e849\u2013e854","journal-title":"Lancet Heal Longev"},{"key":"2062_CR153","first-page":"1891","volume":"29","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Morrone MC, Patrono C et al (2022) Long Covid: where we stand and challenges ahead. Cell Death Differ 29:1891\u20131900","journal-title":"Cell Death Differ"},{"key":"2062_CR154","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/nu17071287","volume":"17","author":"N Marchesi","year":"2025","unstructured":"Marchesi N, Allegri M, Bruno GM et al (2025) Exploring the potential of dietary supplements to alleviate pain due to long COVID. Nutrients 17:1287","journal-title":"Nutrients"},{"key":"2062_CR155","doi-asserted-by":"publisher","first-page":"1138389","DOI":"10.3389\/fpsyt.2023.1138389","volume":"14","author":"M Marchi","year":"2023","unstructured":"Marchi M, Grenzi P, Serafini V et al (2023) Psychiatric symptoms in long-COVID patients: a systematic review. Front Psychiatry 14:1138389","journal-title":"Front Psychiatry"},{"key":"2062_CR156","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42321-9","author":"Z Marjenberg","year":"2023","unstructured":"Marjenberg Z, Leng S, Tascini C et al (2023) Risk of long COVID main symptoms after SARS - CoV - 2 infection: a systematic review and meta - analysis. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-023-42321-9","journal-title":"Sci Rep"},{"key":"2062_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0115733998250889230919185305","volume":"20","author":"BA Marzoog","year":"2024","unstructured":"Marzoog BA (2024) Gastrointestinal tract and kidney injury pathogenesis in post-COVID-19 syndrome. Curr Diabetes Rev 20:1\u20139","journal-title":"Curr Diabetes Rev"},{"key":"2062_CR158","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3390\/v16081266","volume":"16","author":"P McMillan","year":"2024","unstructured":"McMillan P, Turner AJ, Uhal BD (2024) Mechanisms of gut-related viral persistence in long COVID. Viruses 16:1266","journal-title":"Viruses"},{"key":"2062_CR159","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4082\/kjfm.24.0085","volume":"45","author":"ZI Merhavy","year":"2024","unstructured":"Merhavy ZI, Junor T, Gonzalez A et al (2024) Long COVID: a comprehensive overview of the signs and symptoms across multiple organ systems. Korean J Fam Med 45:305","journal-title":"Korean J Fam Med"},{"key":"2062_CR160","doi-asserted-by":"publisher","first-page":"1582783","DOI":"10.3389\/fimmu.2025.1582783","volume":"16","author":"KP Michalak","year":"2025","unstructured":"Michalak KP, Michalak AZ, Brenk-Krakowska A (2025) Acute COVID-19 and longCOVID syndrome\u2013molecular implications for therapeutic strategies-review. Front Immunol 16:1582783","journal-title":"Front Immunol"},{"key":"2062_CR161","doi-asserted-by":"crossref","unstructured":"Mirfazeli FS, Sarabi-Jamab A, kordi A, et al (2021) Acute phase clinical manifestation of COVID-19 is linked to long-COVID symptoms; A 9-month follow-up study. medRxiv 2007\u20132021","DOI":"10.1101\/2021.07.13.21260482"},{"key":"2062_CR162","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s10072-021-05786-y","volume":"43","author":"FS Mirfazeli","year":"2022","unstructured":"Mirfazeli FS, Sarabi-Jamab A, Pereira-Sanchez V et al (2022) Chronic fatigue syndrome and cognitive deficit are associated with acute-phase neuropsychiatric manifestations of COVID-19: a 9-month follow-up study. Neurol Sci 43:2231\u20132239","journal-title":"Neurol Sci"},{"key":"2062_CR163","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1080\/13548506.2025.2496831","volume":"30","author":"SS Mishra","year":"2025","unstructured":"Mishra SS, Gupta H, Gandhi TK, Biswal BB (2025) Psychological symptoms and risk factors associated with long COVID: a study on the Indian cohort. Psychol Health Med 30:2372","journal-title":"Psychol Health Med"},{"key":"2062_CR164","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.4103\/jfmpc.jfmpc_2283_21","volume":"11","author":"R Mittal","year":"2022","unstructured":"Mittal R, Chourasia N, Bharti VK et al (2022) Blood-based biomarkers for diagnosis, prognosis, and severity prediction of COVID-19: opportunities and challenges. J Fam Med Prim Care 11:4330\u20134341","journal-title":"J Fam Med Prim Care"},{"key":"2062_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155873","volume":"154","author":"L Mobasheri","year":"2022","unstructured":"Mobasheri L, Nasirpour MH, Masoumi E et al (2022) SARS-CoV-2 triggering autoimmune diseases. Cytokine 154:155873","journal-title":"Cytokine"},{"key":"2062_CR166","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1007\/s11357-024-01165-5","volume":"46","author":"T Molnar","year":"2024","unstructured":"Molnar T, Lehoczki A, Fekete M et al (2024) Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches. Geroscience 46:5267\u20135286","journal-title":"Geroscience"},{"key":"2062_CR167","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12916-021-02222-y","volume":"20","author":"D Munblit","year":"2022","unstructured":"Munblit D, Nicholson TR, Needham DM et al (2022) Studying the post-COVID-19 condition: research challenges, strategies, and importance of core outcome set development. BMC Med 20:50","journal-title":"BMC Med"},{"key":"2062_CR168","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1001\/jamapediatrics.2021.2281","volume":"175","author":"D Munblit","year":"2021","unstructured":"Munblit D, Sigfrid L, Warner JO (2021) Setting priorities to address research gaps in long-term COVID-19 outcomes in children. JAMA Pediatr 175:1095\u20131096","journal-title":"JAMA Pediatr"},{"key":"2062_CR169","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41590-023-01445-w","volume":"24","author":"J Muri","year":"2023","unstructured":"Muri J, Cecchinato V, Cavalli A et al (2023) Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course. Nat Immunol 24:604\u2013611","journal-title":"Nat Immunol"},{"key":"2062_CR170","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.medj.2022.04.001","volume":"3","author":"A Natarajan","year":"2022","unstructured":"Natarajan A, Zlitni S, Brooks EF et al (2022) Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med 3:371\u2013387","journal-title":"Med"},{"key":"2062_CR171","doi-asserted-by":"crossref","unstructured":"Navis A (2023) A review of neurological symptoms in long COVID and clinical management. In: Seminars in Neurology. Thieme Medical Publishers, Inc., pp 286\u2013296","DOI":"10.1055\/s-0043-1767781"},{"key":"2062_CR172","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1111\/ene.16027","volume":"30","author":"A Nicotra","year":"2023","unstructured":"Nicotra A, Masserini F, Calcaterra F et al (2023) What do we mean by long COVID? A scoping review of the cognitive sequelae of SARS\u2010CoV\u20102 infection. Eur J Neurol 30:3968\u20133978","journal-title":"Eur J Neurol"},{"key":"2062_CR173","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMp2304550","volume":"388","author":"J\u017d Nikolich","year":"2023","unstructured":"Nikolich J\u017d, Rosen CJ (2023) Toward comprehensive care for long covid. N Engl J Med 388:2113\u20132115","journal-title":"N Engl J Med"},{"key":"2062_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101075","volume":"60","author":"JM Nunes","year":"2023","unstructured":"Nunes JM, Kell DB, Pretorius E (2023) Cardiovascular and haematological pathology in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): a role for viruses. Blood Rev 60:101075. https:\/\/doi.org\/10.1016\/j.blre.2023.101075","journal-title":"Blood Rev"},{"key":"2062_CR175","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2021.0265","author":"M Nurek","year":"2021","unstructured":"Nurek M, Rayner C, Freyer A et al (2021) Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study. Br J Gen Pract. https:\/\/doi.org\/10.3399\/BJGP.2021.0265","journal-title":"Br J Gen Pract"},{"key":"2062_CR176","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1080\/09638288.2024.2382904","volume":"47","author":"KK O\u2019Brien","year":"2025","unstructured":"O\u2019Brien KK, McDuff K, Chattu VK et al (2025) A framework of research priorities in COVID rehabilitation from the Rehabilitation Science Research Network for COVID: an international consultation involving qualitative and quantitative research. Disabil Rehabil 47:1754\u20131763","journal-title":"Disabil Rehabil"},{"key":"2062_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113464","author":"M Oliveira","year":"2021","unstructured":"Oliveira M, Hoste H, Cust\u00f3dio L (2021) A systematic review on the ethnoveterinary uses of mediterranean salt-tolerant plants: exploring its potential use as fodder, nutraceuticals or phytotherapeutics in ruminant production. J Ethnopharmacol. https:\/\/doi.org\/10.1016\/j.jep.2020.113464","journal-title":"J Ethnopharmacol"},{"key":"2062_CR178","doi-asserted-by":"publisher","DOI":"10.1111\/hex.70290","volume":"28","author":"E Ortega\u2010Martin","year":"2025","unstructured":"Ortega\u2010Martin E, Alvarez\u2010Galvez J (2025) Living with long COVID: everyday experiences, health information barriers and patients\u2019 quality of life. Health Expect 28:e70290","journal-title":"Health Expect"},{"key":"2062_CR179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/covid5030041","volume":"5","author":"K Ozanic","year":"2025","unstructured":"Ozanic K, Watanabe ASA, Machado ABF et al (2025) Long COVID: general perceptions and challenges in diagnosis and management. Covid 5:1\u201314. https:\/\/doi.org\/10.3390\/covid5030041","journal-title":"Covid"},{"key":"2062_CR180","doi-asserted-by":"publisher","first-page":"28","DOI":"10.54614\/ClinSciNutr.2022.210718","volume":"4","author":"Y \u00d6zt\u00fcrk","year":"2022","unstructured":"\u00d6zt\u00fcrk Y, Halil M (2022) Malnutrition and nutritional care in patients with COVID-19. Clin Sci Nutr 4:28\u201332","journal-title":"Clin Sci Nutr"},{"key":"2062_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109536","author":"S Padilla","year":"2024","unstructured":"Padilla S, Ledesma C, Garc\u00eda-Abell\u00e1n J et al (2024) Long COVID across SARS-CoV-2 variants, lineages, and sublineages. iScience. https:\/\/doi.org\/10.1016\/j.isci.2024.109536","journal-title":"iScience"},{"key":"2062_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2021.100178","author":"Z Parolin","year":"2022","unstructured":"Parolin Z, Lee EK (2022) The role of poverty and racial discrimination in exacerbating the health consequences of COVID-19. Lancet Reg Health. https:\/\/doi.org\/10.1016\/j.lana.2021.100178","journal-title":"Lancet Reg Health"},{"key":"2062_CR183","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s10020-022-00548-8","volume":"28","author":"MA Patel","year":"2022","unstructured":"Patel MA, Knauer MJ, Nicholson M et al (2022) Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism. Mol Med 28:122","journal-title":"Mol Med"},{"key":"2062_CR184","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/jcm14051475","volume":"14","author":"R Patrascu","year":"2025","unstructured":"Patrascu R, Dumitru CS (2025) Advances in understanding inflammation and tissue damage: markers of persistent sequelae in COVID-19 patients. J Clin Med 14:1475","journal-title":"J Clin Med"},{"key":"2062_CR185","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.700782","volume":"12","author":"BK Patterson","year":"2021","unstructured":"Patterson BK, Guevara-Coto J, Yogendra R et al (2021) Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front Immunol 12:700782","journal-title":"Front Immunol"},{"key":"2062_CR186","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","volume":"187","author":"MJ Peluso","year":"2024","unstructured":"Peluso MJ, Deeks SG (2024) Mechanisms of long COVID and the path toward therapeutics. Cell 187:5500\u20135529. https:\/\/doi.org\/10.1016\/j.cell.2024.07.054","journal-title":"Cell"},{"key":"2062_CR187","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ana.26350","volume":"91","author":"MJ Peluso","year":"2022","unstructured":"Peluso MJ, Deeks SG, Mustapic M et al (2022a) SARS\u2010CoV\u20102 and mitochondrial proteins in neural\u2010derived exosomes of COVID\u201019. Ann Neurol 91:772\u2013781","journal-title":"Ann Neurol"},{"key":"2062_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109518","author":"MJ Peluso","year":"2021","unstructured":"Peluso MJ, Deitchman AN, Torres L et al (2021a) Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2021.109518","journal-title":"Cell Rep"},{"key":"2062_CR189","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163669","author":"MJ Peluso","year":"2023","unstructured":"Peluso MJ, Deveau T-M, Munter SE et al (2023a) Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI163669","journal-title":"J Clin Invest"},{"key":"2062_CR190","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/infdis\/jiab490","volume":"224","author":"MJ Peluso","year":"2021","unstructured":"Peluso MJ, Lu S, Tang AF et al (2021b) Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis 224:1839\u20131848","journal-title":"J Infect Dis"},{"key":"2062_CR191","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/infdis\/jiac372","volume":"227","author":"MJ Peluso","year":"2023","unstructured":"Peluso MJ, Mitchell A, Wang CY et al (2023b) Low prevalence of interferon \u03b1 autoantibodies in people experiencing symptoms of post\u2013coronavirus disease 2019 (COVID-19) conditions, or long COVID. J Infect Dis 227:246\u2013250","journal-title":"J Infect Dis"},{"key":"2062_CR192","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200003","volume":"9","author":"MJ Peluso","year":"2022","unstructured":"Peluso MJ, Sans HM, Forman CA et al (2022b) Plasma markers of neurologic injury and inflammation in people with self-reported neurologic postacute sequelae of SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm 9:e200003","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2062_CR193","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11050556","volume":"11","author":"HR Perez-Gomez","year":"2022","unstructured":"Perez-Gomez HR, Morfin-Otero R, Gonzalez-Diaz E et al (2022) The multifaceted manifestations of multisystem inflammatory syndrome during the SARS-CoV-2 pandemic. Pathogens 11:556","journal-title":"Pathogens"},{"key":"2062_CR194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2023.1117464","volume":"14","author":"R Perumal","year":"2023","unstructured":"Perumal R, Shunmugam L, Naidoo K et al (2023a) Long COVID: a review and proposed visualization of the complexity of long COVID. Front Immunol 14:1\u201318. https:\/\/doi.org\/10.3389\/fimmu.2023.1117464","journal-title":"Front Immunol"},{"key":"2062_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106935","author":"R Perumal","year":"2023","unstructured":"Perumal R, Shunmugam L, Naidoo K et al (2023b) Biological mechanisms underpinning the development of long COVID. iScience. https:\/\/doi.org\/10.1016\/j.isci.2023.106935","journal-title":"iScience"},{"key":"2062_CR196","doi-asserted-by":"publisher","DOI":"10.1177\/13591053251325112","author":"S Petker","year":"2025","unstructured":"Petker S, Ogden J (2025) Patients\u2019 experiences of living with Long Covid and their beliefs about the role of psychology in their condition. J Health Psychol. https:\/\/doi.org\/10.1177\/13591053251325112","journal-title":"J Health Psychol"},{"key":"2062_CR197","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","volume":"23","author":"C Phetsouphanh","year":"2022","unstructured":"Phetsouphanh C, Darley DR, Wilson DB et al (2022) Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol 23:210\u2013216","journal-title":"Nat Immunol"},{"key":"2062_CR198","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3889\/oamjms.2022.9899","volume":"10","author":"IMY Prabawa","year":"2022","unstructured":"Prabawa IMY, Silakarma D, Prabawa IPY, Manuaba IBAP (2022) Physical rehabilitation therapy for long covid-19 patient with respiratory sequelae: a systematic review. Open Access Maced J Med Sci 10:468\u2013474","journal-title":"Open Access Maced J Med Sci"},{"key":"2062_CR199","doi-asserted-by":"crossref","unstructured":"Pretorius E, Venter C, Laubscher GJ, et al (2021a) Combined triple treatment of fibrin amyloid microclots and platelet pathology in individuals with Long COVID\/Post-Acute Sequelae of COVID-19 (PASC) can resolve their persistent symptoms","DOI":"10.21203\/rs.3.rs-1205453\/v1"},{"key":"2062_CR200","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12933-021-01359-7","volume":"20","author":"E Pretorius","year":"2021","unstructured":"Pretorius E, Vlok M, Venter C et al (2021b) Persistent clotting protein pathology in long COVID\/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol 20:172","journal-title":"Cardiovasc Diabetol"},{"key":"2062_CR201","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1016\/S1473-3099(24)00769-2","volume":"25","author":"AD Proal","year":"2025","unstructured":"Proal AD, Aleman S, Bomsel M et al (2025) Targeting the SARS-CoV-2 reservoir in long COVID. Lancet Infect Dis 25:e294\u2013e306","journal-title":"Lancet Infect Dis"},{"key":"2062_CR202","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/vaccines9050436","volume":"9","author":"AA Rabaan","year":"2021","unstructured":"Rabaan AA, Al-Ahmed SH, Muhammad J et al (2021) Role of inflammatory cytokines in COVID-19 patients: a review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm. Vaccines 9:436","journal-title":"Vaccines"},{"key":"2062_CR203","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/17512433.2021.1902303","volume":"14","author":"S Rahman","year":"2021","unstructured":"Rahman S, Montero MTV, Rowe K et al (2021) Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol 14:601\u2013621","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2062_CR204","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1001\/jama.2024.13551","volume":"332","author":"S Rao","year":"2024","unstructured":"Rao S (2024) Uncovering long COVID in children. JAMA 332:1150\u20131152","journal-title":"JAMA"},{"key":"2062_CR205","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11886-020-01328-8","volume":"22","author":"JS Rico-Mesa","year":"2020","unstructured":"Rico-Mesa JS, Rosas D, Ahmadian-Tehrani A et al (2020) The role of anticoagulation in COVID-19-induced hypercoagulability. Curr Cardiol Rep 22:53","journal-title":"Curr Cardiol Rep"},{"key":"2062_CR206","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2021-0462","volume":"21","author":"T Robbins","year":"2021","unstructured":"Robbins T, Gonevski M, Clark C et al (2021) Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. Clin Med (Northfield Il) 21:e629\u2013e632","journal-title":"Clin Med (Northfield Il)"},{"key":"2062_CR207","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119893119","volume":"119","author":"PC Robinson","year":"2022","unstructured":"Robinson PC, Liew DFL, Tanner HL et al (2022) COVID-19 therapeutics: challenges and directions for the future. Proc Natl Acad Sci U S A 119:e2119893119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2062_CR208","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03328-4","volume":"20","author":"M Rojas","year":"2022","unstructured":"Rojas M, Rodr\u00edguez Y, Acosta-Ampudia Y et al (2022) Autoimmunity is a hallmark of post-COVID syndrome. J Transl Med 20:129","journal-title":"J Transl Med"},{"key":"2062_CR209","doi-asserted-by":"publisher","DOI":"10.1177\/21649561211056597","volume":"10","author":"A Roth","year":"2021","unstructured":"Roth A, Chan PS, Jonas W (2021) Addressing the long COVID crisis: integrative health and long COVID. Glob Adv Health Med 10:21649561211056596. https:\/\/doi.org\/10.1177\/21649561211056597","journal-title":"Glob Adv Health Med"},{"key":"2062_CR210","doi-asserted-by":"crossref","unstructured":"Rudroff T (2025) Pharmacological and Non-pharmacological Interventions. In: Long COVID Fatigue: Clinical Sciences, Artificial Intelligence and the Future of Brain Health. Springer, pp 135\u2013154","DOI":"10.1007\/978-3-031-89474-9_16"},{"key":"2062_CR211","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01227-8","volume":"46","author":"SJ Russell","year":"2024","unstructured":"Russell SJ, Parker K, Lehoczki A et al (2024) Post-acute sequelae of SARS-CoV-2 infection (Long COVID) in older adults. Geroscience 46:6563\u20136581","journal-title":"Geroscience"},{"key":"2062_CR212","doi-asserted-by":"publisher","DOI":"10.3390\/diseases11040163","author":"JC S\u00e1nchez-Garc\u00eda","year":"2023","unstructured":"S\u00e1nchez-Garc\u00eda JC, Reinoso-Cobo A, Piqueras-Sola B et al (2023) Long COVID and physical therapy: a systematic review. Diseases. https:\/\/doi.org\/10.3390\/diseases11040163","journal-title":"Diseases"},{"key":"2062_CR213","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ppul.26779","volume":"59","author":"F Sansone","year":"2024","unstructured":"Sansone F, Di Filippo P, Russo D et al (2024) Lung function assessment in children with Long-Covid syndrome. Pediatr Pulmonol 59:472\u2013481. https:\/\/doi.org\/10.1002\/ppul.26779","journal-title":"Pediatr Pulmonol"},{"key":"2062_CR214","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11082239","volume":"11","author":"L Santoro","year":"2023","unstructured":"Santoro L, Zaccone V, Falsetti L et al (2023) Role of endothelium in cardiovascular sequelae of long COVID. Biomedicines 11:2239","journal-title":"Biomedicines"},{"key":"2062_CR215","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7759\/cureus.44588","volume":"15","author":"F Sapna","year":"2023","unstructured":"Sapna F, Deepa F, Sakshi F et al (2023) Unveiling the mysteries of long COVID syndrome: exploring the distinct tissue and organ pathologies linked to prolonged COVID-19 symptoms. Cureus 15:1\u201312. https:\/\/doi.org\/10.7759\/cureus.44588","journal-title":"Cureus"},{"key":"2062_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103445","volume":"22","author":"FS Seibert","year":"2023","unstructured":"Seibert FS, Stervbo U, Wiemers L et al (2023) Severity of neurological long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors. Autoimmun Rev 22:103445","journal-title":"Autoimmun Rev"},{"key":"2062_CR217","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijid.2023.05.007","volume":"133","author":"C Servier","year":"2023","unstructured":"Servier C, Porcher R, Pane I et al (2023) Trajectories of the evolution of post-COVID-19 condition, up to two years after symptoms onset. Int J Infect Dis 133:67\u201374. https:\/\/doi.org\/10.1016\/j.ijid.2023.05.007","journal-title":"Int J Infect Dis"},{"key":"2062_CR218","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00970-2022","author":"K Son","year":"2023","unstructured":"Son K, Jamil R, Chowdhury A et al (2023) Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.00970-2022","journal-title":"Eur Respir J"},{"key":"2062_CR219","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2021.679397","volume":"9","author":"LE S\u00f8vold","year":"2021","unstructured":"S\u00f8vold LE, Naslund JA, Kousoulis AA et al (2021) Prioritizing the mental health and well-being of healthcare workers: an urgent global public health priority. Front Public Health 9:1\u201312. https:\/\/doi.org\/10.3389\/fpubh.2021.679397","journal-title":"Front Public Health"},{"key":"2062_CR220","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40588-024-00217-w","volume":"11","author":"FR Spera","year":"2024","unstructured":"Spera FR, Mistrulli R, Salerno L et al (2024) Post-COVID postural orthostatic tachycardia syndrome and inappropriate sinus tachycardia in the pediatric population. Curr Clin Microbiol Rep 11:115\u2013125. https:\/\/doi.org\/10.1007\/s40588-024-00217-w","journal-title":"Curr Clin Microbiol Rep"},{"key":"2062_CR221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbiomolbio.2023.04.008","volume":"182","author":"S Srikanth","year":"2023","unstructured":"Srikanth S, Boulos JR, Dover T et al (2023) Identification and diagnosis of long COVID-19: a scoping review. Prog Biophys Mol Biol 182:1\u20137","journal-title":"Prog Biophys Mol Biol"},{"key":"2062_CR222","doi-asserted-by":"publisher","DOI":"10.1177\/20406223221076890","volume":"13","author":"M-I Stefanou","year":"2022","unstructured":"Stefanou M-I, Palaiodimou L, Bakola E et al (2022) Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis 13:20406223221076890","journal-title":"Ther Adv Chronic Dis"},{"key":"2062_CR223","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","volume":"612","author":"SR Stein","year":"2022","unstructured":"Stein SR, Ramelli SC, Grazioli A et al (2022) SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612:758\u2013763","journal-title":"Nature"},{"key":"2062_CR224","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su Y, Yuan D, Chen DG et al (2022) Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185:881\u2013895","journal-title":"Cell"},{"key":"2062_CR225","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","volume":"28","author":"A Subramanian","year":"2022","unstructured":"Subramanian A, Nirantharakumar K, Hughes S et al (2022) Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med 28:1706\u20131714. https:\/\/doi.org\/10.1038\/s41591-022-01909-w","journal-title":"Nat Med"},{"key":"2062_CR226","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","volume":"27","author":"CH Sudre","year":"2021","unstructured":"Sudre CH, Murray B, Varsavsky T et al (2021) Attributes and predictors of long COVID. Nat Med 27:626\u2013631","journal-title":"Nat Med"},{"key":"2062_CR227","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1507\/endocrj.EJ22-0093","volume":"69","author":"N Sunada","year":"2022","unstructured":"Sunada N, Honda H, Nakano Y et al (2022) Hormonal trends in patients suffering from long COVID symptoms. Endocr J 69:1173\u20131181","journal-title":"Endocr J"},{"key":"2062_CR228","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1093\/cid\/ciac722","volume":"76","author":"Z Swank","year":"2023","unstructured":"Swank Z, Senussi Y, Manickas-Hill Z et al (2023) Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis 76:e487\u2013e490","journal-title":"Clin Infect Dis"},{"key":"2062_CR229","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.00085","volume":"10","author":"M Taberna","year":"2020","unstructured":"Taberna M, Gil Moncayo F, Jan\u00e9-Salas E et al (2020) The multidisciplinary team (MDT) approach and quality of care. Front Oncol 10:1\u201316","journal-title":"Front Oncol"},{"key":"2062_CR230","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07153-4","volume":"22","author":"F Tejerina","year":"2022","unstructured":"Tejerina F, Catalan P, Rodriguez-Grande C et al (2022) Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect Dis 22:211","journal-title":"BMC Infect Dis"},{"key":"2062_CR231","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/occmed\/kqab109","volume":"71","author":"M Tempany","year":"2021","unstructured":"Tempany M, Leonard A, Prior AR et al (2021) The potential impact of post-COVID symptoms in the healthcare sector. Occup Med (Chic Ill) 71:284\u2013289","journal-title":"Occup Med (Chic Ill)"},{"key":"2062_CR232","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/ajh.25829","volume":"95","author":"E Terpos","year":"2020","unstructured":"Terpos E, Ntanasis\u2010Stathopoulos I, Elalamy I et al (2020) Hematological findings and complications of COVID\u201019. Am J Hematol 95:834\u2013847","journal-title":"Am J Hematol"},{"key":"2062_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.smhs.2025.09.002","author":"S Thangaleela","year":"2025","unstructured":"Thangaleela S, Wang C-K (2025) Impact of nutrition on long COVID. Sport Med Heal Sci. https:\/\/doi.org\/10.1016\/j.smhs.2025.09.002","journal-title":"Sport Med Heal Sci"},{"key":"2062_CR234","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1136\/bjophthalmol-2020-316586","volume":"105","author":"ZX Thng","year":"2021","unstructured":"Thng ZX, De Smet MD, Lee CS et al (2021) COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs. Br J Ophthalmol 105:306\u2013310","journal-title":"Br J Ophthalmol"},{"key":"2062_CR235","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s40291-024-00731-z","volume":"28","author":"C Thomas","year":"2024","unstructured":"Thomas C, Faghy MA, Chidley C et al (2024) Blood biomarkers of long COVID: a systematic review. Mol Diagn Ther 28:537\u2013574","journal-title":"Mol Diagn Ther"},{"key":"2062_CR236","first-page":"61","volume":"11","author":"AY-K Thye","year":"2022","unstructured":"Thye AY-K, Law JW-F, Tan LT-H et al (2022) Psychological symptoms in COVID-19 patients: insights into pathophysiology and risk factors of long COVID-19. Biology (Basel) 11:61","journal-title":"Biology (Basel)"},{"key":"2062_CR237","doi-asserted-by":"publisher","DOI":"10.3390\/biom15070928","volume":"15","author":"M Tobi","year":"2025","unstructured":"Tobi M, Chaudhari D, Ryan EP et al (2025) Immune signatures in post-acute sequelae of COVID-19 (PASC) and myalgia\/chronic fatigue syndrome (ME\/CFS): insights from the fecal microbiome and serum cytokine profiles. Biomolecules 15:928","journal-title":"Biomolecules"},{"key":"2062_CR238","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s00431-023-05360-y","volume":"183","author":"N Toepfner","year":"2024","unstructured":"Toepfner N, Brinkmann F, Augustin S et al (2024) Long COVID in pediatrics\u2014epidemiology, diagnosis, and management. Eur J Pediatr 183:1543\u20131553","journal-title":"Eur J Pediatr"},{"key":"2062_CR239","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2022.033","volume":"14","author":"M Tong","year":"2022","unstructured":"Tong M, Yan X, Jiang Y et al (2022) Endothelial biomarkers in patients recovered from COVID-19 one year after hospital discharge: a cross-sectional study. Mediterr J Hematol Infect Dis 14:e2022033","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2062_CR240","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10238-023-01256-1","volume":"24","author":"E Torki","year":"2024","unstructured":"Torki E, Hoseininasab F, Moradi M et al (2024) The demographic, laboratory and genetic factors associated with long Covid-19 syndrome: a case\u2013control study. Clin Exp Med 24:1\u201313. https:\/\/doi.org\/10.1007\/s10238-023-01256-1","journal-title":"Clin Exp Med"},{"key":"2062_CR241","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2021.09.316","volume":"46","author":"RS Torrinhas","year":"2021","unstructured":"Torrinhas RS, Ribeiro PC, Syagha Y et al (2021) Gastrointestinal and sensory symptoms, nutritional management, and energy-protein intake in hospitalized patients with covid-19. Clin Nutr ESPEN 46:S653","journal-title":"Clin Nutr ESPEN"},{"key":"2062_CR242","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072430","volume":"13","author":"L Townsend","year":"2021","unstructured":"Townsend L, Dyer AH, McCluskey P et al (2021) Investigating the relationship between vitamin D and persistent symptoms following SARS-CoV-2 infection. Nutrients 13:2430","journal-title":"Nutrients"},{"key":"2062_CR243","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310458","volume":"24","author":"D Tsilingiris","year":"2023","unstructured":"Tsilingiris D, Vallianou NG, Karampela I et al (2023) Laboratory findings and biomarkers in long COVID: what do we know so far? Insights into epidemiology, pathogenesis, therapeutic perspectives and challenges. Int J Mol Sci 24:10458","journal-title":"Int J Mol Sci"},{"key":"2062_CR244","unstructured":"Vakani K (2024) The cognitive sequalae of COVID-19 and long COVID-the inconspicuous wound of the pandemic"},{"key":"2062_CR245","doi-asserted-by":"publisher","DOI":"10.5501\/wjv.v13.i2.92521","volume":"13","author":"T Velikova","year":"2024","unstructured":"Velikova T, Valkov H, Aleksandrova A et al (2024) Harnessing immunity: immunomodulatory therapies in COVID-19. World J Virol 13:92521. https:\/\/doi.org\/10.5501\/wjv.v13.i2.92521","journal-title":"World J Virol"},{"key":"2062_CR246","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3390\/nu13041154","volume":"13","author":"C Vollbracht","year":"2021","unstructured":"Vollbracht C, Kraft K (2021) Feasibility of vitamin C in the treatment of post viral fatigue with focus on long COVID, based on a systematic review of IV vitamin C on fatigue. Nutrients 13:1154","journal-title":"Nutrients"},{"key":"2062_CR247","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.861703","volume":"12","author":"C Wang","year":"2022","unstructured":"Wang C, Yu C, Jing H et al (2022) Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation. Front Cell Infect Microbiol 12:861703","journal-title":"Front Cell Infect Microbiol"},{"key":"2062_CR248","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","volume":"395","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang D, Du G et al (2020) Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet (London, England) 395:1569\u20131578. https:\/\/doi.org\/10.1016\/S0140-6736(20)31022-9","journal-title":"Lancet (London, England)"},{"key":"2062_CR249","doi-asserted-by":"publisher","DOI":"10.1590\/1678-9865202033e200212","volume":"33","author":"TK Weber","year":"2020","unstructured":"Weber TK, Leandro-Merhi VA, Bernasconi I, Oliveira MRMD (2020) Nutritional therapy in hospital care of in-patients with Covid-19: evidence, consensus and practice guidelines. Rev Nutr 33:e200212","journal-title":"Rev Nutr"},{"key":"2062_CR250","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1186\/s12913-022-08384-6","volume":"22","author":"S Wolf","year":"2022","unstructured":"Wolf S, Zechmeister-Koss I, Erd\u00f6s J (2022) Possible long COVID healthcare pathways: a scoping review. BMC Health Serv Res 22:1076","journal-title":"BMC Health Serv Res"},{"key":"2062_CR251","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10456-023-09878-5","volume":"27","author":"X Wu","year":"2024","unstructured":"Wu X, Xiang M, Jing H et al (2024) Damage to endothelial barriers and its contribution to long COVID. Angiogenesis 27:5\u201322","journal-title":"Angiogenesis"},{"key":"2062_CR252","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-023-01086-z","volume":"12","author":"J-X Yin","year":"2023","unstructured":"Yin J-X, Agbana YL, Sun Z-S et al (2023) Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis. Infect Dis Poverty 12:43","journal-title":"Infect Dis Poverty"},{"key":"2062_CR253","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2424","volume":"33","author":"SJ Yong","year":"2023","unstructured":"Yong SJ, Halim A, Halim M et al (2023a) Inflammatory and vascular biomarkers in post\u2010COVID\u201019 syndrome: a systematic review and meta\u2010analysis of over 20 biomarkers. Rev Med Virol 33:e2424","journal-title":"Rev Med Virol"},{"key":"2062_CR254","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2424","volume":"33","author":"SJ Yong","year":"2023","unstructured":"Yong SJ, Halim A, Halim M et al (2023b) Inflammatory and vascular biomarkers in post-COVID-19 syndrome: a systematic review and meta-analysis of over 20 biomarkers. Rev Med Virol 33:e2424. https:\/\/doi.org\/10.1002\/rmv.2424","journal-title":"Rev Med Virol"},{"key":"2062_CR255","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2315","volume":"32","author":"SJ Yong","year":"2022","unstructured":"Yong SJ, Liu S (2022) Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol 32:e2315","journal-title":"Rev Med Virol"},{"key":"2062_CR256","doi-asserted-by":"publisher","DOI":"10.1172\/JCI149633","author":"LM Yonker","year":"2021","unstructured":"Yonker LM, Gilboa T, Ogata AF et al (2021) Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI149633","journal-title":"J Clin Invest"},{"key":"2062_CR257","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10070440","volume":"10","author":"P Zamboni","year":"2020","unstructured":"Zamboni P (2020) COVID-19 as a vascular disease: lesson learned from imaging and blood biomarkers. Diagnostics 10:440","journal-title":"Diagnostics"},{"key":"2062_CR258","doi-asserted-by":"publisher","first-page":"6303","DOI":"10.2147\/IJGM.S499905","volume":"17","author":"K Zambrano","year":"2024","unstructured":"Zambrano K, Castillo K, Pe\u00f1aherrera S et al (2024) Understanding post-COVID-19: mechanisms, neurological complications, current treatments, and emerging therapies. Int J Gen Med 17:6303\u20136321","journal-title":"Int J Gen Med"},{"key":"2062_CR259","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e120","author":"D Zhang","year":"2023","unstructured":"Zhang D, Zhou Y, Ma Y et al (2023) Gut microbiota dysbiosis correlates with long COVID-19 at one-year after discharge. J Korean Med Sci. https:\/\/doi.org\/10.3346\/jkms.2023.38.e120","journal-title":"J Korean Med Sci"},{"key":"2062_CR260","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.925703","volume":"9","author":"X Zhou","year":"2022","unstructured":"Zhou X, Yang D, Kong X et al (2022) Case report: pirfenidone in the treatment of post-COVID-19 pulmonary fibrosis. Front Med 9:925703","journal-title":"Front Med"},{"key":"2062_CR261","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264331","volume":"17","author":"N Ziauddeen","year":"2022","unstructured":"Ziauddeen N, Gurdasani D, O\u2019Hara ME et al (2022) Characteristics and impact of long Covid: findings from an online survey. PLoS ONE 17:e0264331","journal-title":"PLoS ONE"},{"key":"2062_CR262","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1097\/INF.0000000000003328","volume":"40","author":"P Zimmermann","year":"2021","unstructured":"Zimmermann P, Pittet LF, Curtis N (2021) How common is long COVID in children and adolescents? Pediatr Infect Dis J 40:e482\u2013e487","journal-title":"Pediatr Infect Dis J"},{"key":"2062_CR263","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/j.gastro.2022.04.037","volume":"163","author":"A Zollner","year":"2022","unstructured":"Zollner A, Koch R, Jukic A et al (2022) Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology 163:495\u2013506","journal-title":"Gastroenterology"},{"key":"2062_CR264","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00296-022-05146-9","volume":"42","author":"S Zubchenko","year":"2022","unstructured":"Zubchenko S, Kril I, Nadizhko O et al (2022) Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int 42:1523\u20131530","journal-title":"Rheumatol Int"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-02062-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-02062-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-02062-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:10:59Z","timestamp":1779797459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-02062-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,30]]},"references-count":264,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2062"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-02062-9","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,30]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest related to the publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}